We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRX Tissue Regenix Group Plc

0.00 (0.0%)
Last Updated: 07:49:57
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 56.00 3,932 07:49:57
Bid Price Offer Price High Price Low Price Open Price
55.00 57.00 56.00 56.00 56.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 24.48M -2.7M -0.0382 -14.66 39.52M
Last Trade Time Trade Type Trade Size Trade Price Currency
12:03:14 O 82 55.00 GBX

Tissue Regenix (TRX) Latest News

Tissue Regenix (TRX) Discussions and Chat

Tissue Regenix (TRX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type

Tissue Regenix (TRX) Top Chat Posts

Top Posts
Posted at 01/12/2023 08:20 by Tissue Regenix Daily Update
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 56p.
Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £39,521,702.
Tissue Regenix has a price to earnings ratio (PE ratio) of -14.66.
This morning TRX shares opened at 56p
Posted at 31/10/2023 14:52 by mickhay3
Trading view trx
Posted at 06/9/2023 13:41 by p1nkfish
Do enough research and the gaps TRX can plug for STRYKER are obvious. Pocket change to them too.
Posted at 05/9/2023 06:47 by cliffpeat
re: "takeover target" - the Chairman's statement on the interims appears to be "setting out the stall" saying:

"We have created a commercially focussed global regenerative medtech company in a high-growth sector focused on soft tissues and bone, with a multi-billion-dollar addressable market opportunity in the United States ('US') alone."

Could you share your workings supporting your suggestion of a potential 2024 profit of $8-10m and what % level of growth (compared to H1) would be required?

The balance sheet shows high inventory, trade debtors and intangibles - and constant reference to EBITDA might be a red flag for some.

Will be interesting to see whether the positive H1 results today move the share price at all.
Posted at 05/9/2023 06:24 by tnt99
With this sort of growth must become a takeover target now we should finally see a re rate to the share price Must be over 1.00 pound by ChristmasAnd the potential for a 8-10 million profit next year and an expected market cap over 100 millionThat's my thoughts It's been a long road though !!
Posted at 04/9/2023 14:03 by tnt99
The path to profitability has been achieved and I hope the figure of between 1 and 3 million profit is made in the results tomorrow Any better should see a jump in the share price
Posted at 31/8/2023 07:41 by p1nkfish
Collateralized loan note.

It's a loan that pays interest and/or issues share in the company in exchange for the lender taking part. There can be a redemption date where the borrowing is paid back via issued shares, or some per year.

The exact terms vary depending on the borrower and they can vary widely. The lenders can be offered a variety of ways to achieve a benefit. Sometimes the major shareholders influence how it is packaged.

It is not the same as issuing discounted shares into the market. I took part in the CRX offering and TRX might make a decent candidate for raising that way especially given the share register.

From memory Mills (Harwood), Sneller (Inthallo) and Griffiths were all on the CRX register and took part. Guess who is on the TRX register.
Posted at 17/7/2023 07:55 by tnt99
Should as I say mean a maiden profit this year and the Australian deal should add to the the year end nicely Hope to see the share price going in the same direction after very little uplift on the news??!!
Posted at 27/3/2023 15:04 by clocktower
The chart is not looking good either is it ?

Once consolidated I expect it to slide further as liquidity drys up.

I could understand it if they had already turned to a profitable business and if the share price was over 2p with a strong forward statement but not now.

You may harp on how good this is but the facts of the slide in share price speaks volumes.

I will even revise my target down now.
Posted at 23/3/2023 15:53 by timmy40
Sorry I cannot see this back at 0.50, the results were positive with +20% revenue across all divisions + cash in the bank to get to break even. The company is growing revenue in existing markets, particularly the US, as elective surgeries return/increase in frequency after Covid. They are expanding to new geographies/markets too, most probably China/Asia in the near future.The consolidation is required given the share price/no of shares in issue. A higher share price will mean the company is more marketable to institutions. It is v common in the US, which is the largest market by far for TRX and their board are Americans ? There is no dilution overall. This is all v good news. TRX's management are doing an excellent job but just imo.
Posted at 11/8/2022 10:11 by livewireplus
:-)) unfortunately no refunds ... but had some good times ... have ended-up married - but as wife earns more than me then can't complain .... pass the Tissue from the left-hand side. An interesting week so far for the TRX share price ....
Tissue Regenix share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |